With a new IND in hand, Graphite Bio plans to begin clinical trials for a CRISPR treatment that will restore normal haemoglobin expression in Sickle...

This week’s IND update looks at two distinct gene-editing strategies for sickle cell disease, both of which are set to enter clinical trials soon...